SCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV) 2021 Announcements . Clinical . Corporate . Regulatory 24.03.2021
SCENESSE® Granted Market Access In Israel 2021 Announcements . Clinical . Corporate . Regulatory 11.02.2021
SCENESSE® DNA REPAIR STUDY IN HEALTHY VOLUNTEERS APPROVED 2020 Announcements . Clinical . Corporate 30.11.2020
Jefferies Virtual London Healthcare Conference Presentation 2020 Announcements . Corporate . Presentation 20.11.2020
MANAGING DIRECTOR’S PRESENTATION TO CLINUVEL ANNUAL GENERAL MEETING 2020 Announcements . Corporate . News . Presentation 11.11.2020
CHAIR’S ADDRESS TO CLINUVEL ANNUAL GENERAL MEETING 2020 Announcements . Corporate . News . Presentation 11.11.2020